Lu Timothy K
SEC CIK 1852301 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SNTI | Senti Biosciences Holdings, Inc. | CEO, Pres, Dir | 639.6K | — | $18.3K | 5 | 2024-02-01 | 2026-03-09 |
Most active insiders at SNTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lu Timothy K | CEO, Dir | — | — |
| 2 | Rajangam Kanya | Pres, Chief Med, Dev. Off | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | 2026-03-09 | SNTI | Senti Biosciences Holdings, Inc. | Lu Timothy K | CEO, Dir | F - Tax | $0.00 | -80.7K | 639.6K | -11% | $0 | |
| 2026-02-03 | 2026-02-02 | SNTI | Senti Biosciences Holdings, Inc. | Lu Timothy K | CEO, Dir | F - Tax | $0.00 | -4,191 | 720.2K | -0.6% | $0 | |
| D | 2025-03-10 | 2025-03-07 | SNTI | Senti Biosciences Holdings, Inc. | Lu Timothy K | CEO, Interim PFO, PAO, Dir | A - Grant | $0.00 | +642.4K | 724.4K | +783% | $0 |
| M | 2025-02-06 | 2025-02-04+ | SNTI | Senti Biosciences Holdings, Inc. | Lu Timothy K | CEO, Dir | S - Sale | $4.11 | -4,467 | 82.1K | -5% | -$18.3K |
| D | 2024-02-02 | 2024-02-01 | SNTI | Senti Biosciences Holdings, Inc. | Lu Timothy K | CEO, Pres, Dir | A - Grant | $0.00 | +306.0K | 865.5K | +55% | $0 |
Purchase Sale Sale after option exercise All abbreviations